Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
about
MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.Emerging targets for radioprotection and radiosensitization in radiotherapy.Mutant monocyte chemoattractant protein-1 protein (7ND) inhibits osteoclast differentiation and reduces oral squamous carcinoma cell bone invasion.Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells
P2860
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@ast
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@en
type
label
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@ast
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@en
prefLabel
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@ast
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
@en
P2093
P2860
P356
P1433
P1476
Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo
@en
P2093
Betty Chang
I-Tsang Chiang
Jeng-Jong Hwang
John Chun-Hao Chen
Wei-Kang Kwang
Yu-Chang Liu
P2860
P2888
P356
10.1038/SREP15391
P407
P50
P577
2015-10-21T00:00:00Z